Expertise in
8
conditions

Anne-laure L. Fauchais

Limoges, FR 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
8
conditions
Limoges, FR 

Overview

Anne-laure Fauchais practices practicing medicine in Limoges, France.

Fauchais is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Giant Cell Arteritis (GCA), Temporal Arteritis, Vasculitis, and Sjogren Syndrome.

They are actively involved in clinical research, co-authoring 72 peer reviewed articles and participating in 5 clinical trials.

Locations

Limoges, France
Other Locations
CHU Brest
Brest, France
Toulouse, France
Lille, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Phase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud Phenomenon
Phase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud Phenomenon
Enrollment Status: Recruiting
Publish Date: July 07, 2026
Intervention Type: Drug
Study Drug: Clopidogrel Treatment
Study Phase: Phase 2/Phase 3
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis: a Phase II, Randomized, Controlled Trial
Safety and Efficacy of Itacitinib in Adults With Systemic Sclerosis: a Phase II, Randomized, Controlled Trial
Enrollment Status: Recruiting
Publish Date: November 20, 2025
Intervention Type: Drug
Study Drug: Itacitinib
Study Phase: Phase 2
Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
Enrollment Status: Completed
Publish Date: August 10, 2026
Intervention Type: Diagnostic test, Other
Study Phase: Not Applicable
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
Incidence and Risk Factors for Infections in Patient Treated With Corticosteroids, Immunosuppressive Drugs or Biotherapy for Immunologic and Inflammatory Diseases
Enrollment Status: Completed
Publish Date: February 03, 2022
Intervention Type: Biological
Primary Sjögren Syndrome
Primary Sjögren Syndrome
Enrollment Status: Completed
Publish Date: January 11, 2019
Intervention Type: Other
View 3 Less Clinical Trials

72 Total Publications

Unraveling giant cell arteritis: From immunopathology to emerging targeted therapies (2026 update).
Unraveling giant cell arteritis: From immunopathology to emerging targeted therapies (2026 update).
Journal: Autoimmunity reviews
Published: February 20, 2026

Frequently Asked Questions about Anne-laure L. Fauchais

Is Anne-laure L. Fauchais a top-rated expert for Giant Cell Arteritis (GCA)?

MediFind is an objective health platform that identifies experts based on real-world data. Anne-laure L. Fauchais is classified as an Distinguished expert for Giant Cell Arteritis (GCA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Anne-laure L. Fauchais participate in research or clinical trials?

Yes. Anne-laure L. Fauchais has published 72 articles and abstracts on conditions like Giant Cell Arteritis (GCA). You can view a list of Anne-laure L. Fauchais's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fauchais's expertise for a condition
ConditionClose
    View All 22 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile